Back to The Med Map

GIP/GLP-1 receptor agonist

Zepbound (tirzepatide)

Generic name: tirzepatide

US Retail Price

$1,060–$1,100/month

With copay card: As low as $25/month (commercially insured)

Manufacturer

Eli Lilly

Used For

Chronic weight management in adults with obesity or overweight with weight-related conditions

Zepbound is the same molecule as Mounjaro (tirzepatide) but FDA-approved for weight loss rather than diabetes. Eli Lilly offers a savings card for commercially insured patients. Eli Lilly also sells Zepbound in single-dose vials directly at a lower price through LillyDirect.

Savings Options for Zepbound (tirzepatide)

Best OptionEli Lilly Savings CardAs low as $25/month

Eli Lilly's Zepbound savings card reduces cost to as low as $25/month for commercially insured patients. Not available for Medicare/Medicaid patients. Enroll at the Zepbound savings page.

Get Lilly Savings Card
Good OptionLillyDirect Self-Pay Vials~$399–$549/month

Eli Lilly sells Zepbound in single-dose vials directly to self-pay patients through LillyDirect at significantly reduced prices compared to auto-injector pens. Requires a prescription and a telehealth visit.

Explore LillyDirect Vials
Medicare/MedicaidNeedyMeds PAP SearchFree for eligible patients

Search NeedyMeds for Zepbound patient assistance programs. Eli Lilly's patient assistance program (Lilly Cares) may provide free medication for qualifying low-income patients.

Search NeedyMeds
Also ConsiderGoodRx DiscountUp to 20% off retail

GoodRx coupons can reduce Zepbound costs at US pharmacies. Savings are modest compared to the savings card but useful for patients who don't qualify for the manufacturer program.

Check GoodRx Price

Frequently Asked Questions

Looking for another medication?

The Med Map covers all 8 categories of savings options for hundreds of drugs.

Back to The Med Map